ABG-WTT Global Life Science Capital Partners GP Ltd

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Reported portfolio value by quarter (23 quarters reported)

$115M $5.51M

Q4 20 Q1 22 Q2 23 Q3 24 Q4 25 Q2 26

$115M in Q4 2020 → $8.55M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding	% of portfolio	Activity	Shares	Value
Ceribell Inc	62.6%	Trimmed 38%	275,328	$5.36M
Rapid Micro Biosystems Inc	37.4%	Unchanged	1,848,296	$3.2M

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

quarter ended June 30, 2026 · filed August 14, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Ceribell Inc	Trimmed	−166,492	−$3.24M	62.6%

quarter ended March 31, 2026 · filed May 18, 2026

No position changes this quarter.

quarter ended December 31, 2025 · filed February 17, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Ceribell Inc	Trimmed	−646,281	−$14.2M	64.4%

quarter ended September 30, 2025 · filed November 14, 2025

No position changes this quarter.

quarter ended June 30, 2025 · filed August 14, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Cg Oncology Inc	Exited	−495,526	−$12.1M	—
Pulmonx Corp	Exited	−60,204	−$405K	—

quarter ended March 31, 2025 · filed May 15, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Rapid Micro Biosystems Inc	Added	+810,000	+$2.14M	12.7%

quarter ended December 31, 2024 · filed February 14, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Ceribell Inc	New	+1,088,101	+$28.2M	64.4%

quarter ended September 30, 2024 · filed November 14, 2024

Company	Action	Shares changed	Value of change	% of portfolio
Cg Oncology Inc	Trimmed	−419,975	−$15.8M	92.9%

Comments